Fibrocell Science is a leading cell and gene therapy company based in New York, NY, dedicated to developing innovative treatments for genetic diseases. With a focus on autologous fibroblast technology and gene therapy, they aim to provide relief to patients and families affected by devastating conditions such as Dystrophic Epidermolysis Bullosa (DEB).
Castle Creek Biosciences, Inc., located in Exton, PA, is committed to helping patients in need through their gene therapy for Dystrophic Epidermolysis Bullosa (DEB). As a leading biotech company, they are focused on developing novel treatments to improve the lives of individuals and families affected by this genetic disease.
Generated from the website